This Plain Language Summary of Publication article (PLSP) from Future Cardiology presents real-world data on diagnostic pathways and how diagnostic delays impact patient health outcomes and quality of life. Light chain amyloidosis is a rare disease where misfolded proteins build up in organs, particularly the heart, causing organ damage and potentially life-threatening complications. The disease affects about 40 per million people in the US and often mimics other conditions, leading to delayed diagnosis that worsens outcomes.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Diagnostic pathways, cardiac manifestations and outcomes in light chain amyloidosis: analysis of a US claims database’ and was published in Openheart.

Visit BMJ using the link to read the original article.